C([O:5][C:6](=[O:34])[CH2:7][N:8]1[CH2:13][CH2:12][N:11]([C:14](=[O:27])[CH2:15][NH:16][C:17]([O:19]CC2C=CC=CC=2)=O)[C@@H:10]([CH2:28][C:29]([O:31][CH3:32])=[O:30])[C:9]1=[O:33])(C)(C)C.[H][H].[ClH:37].[C:38]([C:41]1[CH:49]=[CH:48][C:44](C(O)=O)=[CH:43][CH:42]=1)(=[NH:40])[NH2:39].Cl.CN(C)CCCN=C=NCC.FC(F)(F)C(O)=O.Cl>CO.CN(C)C=O.C(OCC)(=O)C.C(Cl)Cl.[C].[Pd]>[ClH:37].[C:38]([C:41]1[CH:49]=[CH:48][C:44]([C:17]([NH:16][CH2:15][C:14]([N:11]2[CH2:12][CH2:13][N:8]([CH2:7][C:6]([OH:5])=[O:34])[C:9](=[O:33])[C@@H:10]2[CH2:28][C:29]([O:31][CH3:32])=[O:30])=[O:27])=[O:19])=[CH:43][CH:42]=1)(=[NH:39])[NH2:40]In 10 ml of methanol was dissolved 480 mg of (S)-4-(N-benzyloxycarbonylglycyl)-3-methoxycarbonylmethyl-2-oxo-piperazin-1-acetic acid t-butyl ester obtained in Working Example 58. To the solution was added 100 mg of 10% palladium-carbon, and the mixture was stirred for one hour at room temperature in a hydrogen streams. The catalyst was filtered off, and the filtrate was concentrated to give an oily product, which was dissolved in 5 ml of dimethylformamide. To the solution were added 200 mg of 4-amidinobenzoic acid hydrochloride, then 200 mg of (1-(3-dimethylaminopropyl)-3-ethyl carbodiimide hydrochloride. The mixture was stirred for one hour at room temperature. The reaction mixture was diluted with ethyl acetate, washed with a 5% aqueous solution of potassium hydrogensulfate, then a 10% aqueous solution of sodium hydrogencarbonate, followed by drying over anhydrous magnesium sulfate and concentration under reduced pressure to leave an oily product. The oily product was dissolved in 5 ml of methylene chloride. To the solution was added 5 ml of trifluoroacetic acid, and the mixture was stirred for one hour at room temperature. The reaction mixture was concentrate to give a crude product, which was made into hydrochloride with 1N HCl, followed by purification by means of a C18 --ODS column to afford 250 mg of the title compound as colorless powder.
불러오는 중…